HARRISON F. WOOD, M.D.; HENRY D. DIAMOND, M.D., F.A.C.P.; LLOYD F. CRAVER, M.D., F.A.C.P.; ELMER PADER, M.D.; SAMUEL K. ELSTER, M.D.
Since the first description of C-reactive protein by Tillett and Francis in 1930, the occurrence of this substance, which is not present in the blood of normal individuals, has been noted by many workers in a wide variety of disorders.1-4 The first extensive clinical study of C-reactive protein in a specific disease was that of Anderson and McCarty, who found, in a group of 45 patients with acute rheumatic fever, that the determination for this acute phase protein provided a sensitive and useful index of the activity of the disease process.5 Their findings have since been confirmed by other groups,
WOOD HF, DIAMOND HD, CRAVER LF, et al. DETERMINATION OF C-REACTIVE PROTEIN IN THE BLOOD OF PATIENTS WITH HODGKIN'S DISEASE*. Ann Intern Med. 1958;48:823–833. doi: https://doi.org/10.7326/0003-4819-48-4-823
Download citation file:
Published: Ann Intern Med. 1958;48(4):823-833.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use